.jpeg)
To further enhance the global ecosystem of biosimilar, the pharma major Lupin harnessed a strategic step of having a licence and supply deal with the Zentiva Group to commercialise its biosimilar product Certolizumab Pegol in various international te
Kerala has once again been put on high alert, as the state is facing yet another Nipah virus outbreak, and the Centre is taking action. A special joint outbreak response team, with specialists from the National Centre for Disease Control (NCDC)...
Anticipating India's leadership role in BRICS starting 2026, World Health Innovation Forum’s (WHIF) invitation to the BRICS+ Manufacturing Working Group was afforded because of Andhra Pradesh MedTech Zone’s (AMTZ) thought leadership in developing...
Eisai Pharma, a global leader in human healthcare innovation, has announced plans to establish a state-of-the-art Global Capability Centre (GCC) in Visakhapatnam, Andhra Pradesh.
.jpeg){kind=spacer}
The Medical Technology Association of India (MTaI) has strong objections to a recent notification issued by the Maharashtra Medical Council (MMC) that allows homoeopathy practitioners to administer allopathic drugs
India's pharmaceutical sector is undergoing a significant transformation, both in the discovery of new medicines and advancements in drug delivery.
President Donald Trump on Tuesday announced a possible 200% tariff on imported pharmaceuticals. Speaking at a White House cabinet meeting, he said the goal is to push drug companies to make their medicines in the U.S. instead of overse...
In a significant flashpoint for the medical community, allopathic doctors in Maharashtra have threatened to go on strike on July 11 over the state's plan to allow homeopathic practitioners to register with the Maharashtra Medical Council (MMC) by...
The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future
Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...
, CDSCO.jpg)
